Short Description Amazentis co‑founder commercializing urolithin A for mitochondrial health.
Description Biochemist Chris Rinsch spent a decade at Nestlé developing nutraceuticals before co‑founding Amazentis. The company’s flagship product Mitopure (urolithin A) activates mitophagy and improved muscle endurance in placebo‑controlled trials. Rinsch collaborates with the Swiss Institute of Bioinformatics to map dietary polyphenol metabolism.